Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antifolate
    (3)
  • Apoptosis
    (2)
  • Autophagy
    (3)
  • DHFR
    (3)
  • DNA/RNA Synthesis
    (3)
Filter
Search Result
Results for "

ly-231514

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    3
    TargetMol | Activity
Pemetrexed
T0189137281-23-3
Pemetrexed (LY-231514 Disodium Hydrate), a guanine-derived antineoplastic agent, binds to and inhibits the enzyme thymidylate synthase (TS).
  • $33
In Stock
Size
QTY
Pemetrexed disodium
T0189L150399-23-8
Pemetrexed disodium (LY-231514) is a parenterally administered folate antagonist and antineoplastic agent, used in the treatment of non-small cell lung cancer and malignant mesothelioma. Pemetrexed disodium therapy has been associated with moderate rates of serum enzyme elevations during therapy, but has not been convincingly linked to instances of acute, clinically apparent liver injury.
  • $37
In Stock
Size
QTY
Pemetrexed disodium hemipenta hydrate
T6226357166-30-4
Pemetrexed disodium hemipenta hydrate (LY-231514 Disodium Hydrate) is a new-type antifolate and antimetabolite for TS, DHFR, and GARFT. The Ki of Pemetrexed Disodium Hydrate for TS, DHFR and GARFT is 1.3 nM, 7.2 nM and 65 nM, respectively.
  • $33
In Stock
Size
QTY
TargetMol | Citations Cited